Fingerprint
Dive into the research topics of 'Pioglitazone and alogliptin combination therapy in type 2 diabetes: A pathophysiologically sound treatment'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pioglitazone and alogliptin combination therapy in type 2 diabetes: A pathophysiologically sound treatment
Curtis Triplitt, Eugenio Cersosimo, Ralph A. DeFronzo
Research output: Contribution to journal › Review article › peer-review
23
Scopus
citations